发明名称 Alphavirus vectors and virosomes with modified HIV genes for use in vaccines
摘要 The present invention provides methods and compositions comprising a population of alphavirus replicon particles comprising two or more isolated nucleic acids selected from 1) an isolated nucleic acid encoding an env gene product or an immunogenic fragment thereof of a human immunodeficiency virus, 2) an isolated nucleic acid encoding a gag gene product or an immunogenic fragment thereof of a human immunodeficiency virus, wherein the gag gene product or immunogenic fragment thereof is modified to inhibit formation of virus-like particles containing the gag gene product or the immunogenic fragment thereof and their release from a cell, and 3) an isolated nucleic acid encoding a pol gene product or an immunogenic fragment thereof of a human immunodeficiency virus, wherein the pol gene product or immunogenic fragment thereof is modified to inhibit protease, integrase, RNase H and/or reverse transcriptase activity, and wherein the nucleic acids are each contained within a separate alphavirus replicon particle.
申请公布号 US2002141975(A1) 申请公布日期 2002.10.03
申请号 US20010991258 申请日期 2001.11.16
申请人 ALPHAVAX, INC. 发明人 OLMSTED ROBERT;KEITH PAULA;DRYGA SERGEY;CALEY IAN;MAUGHAN MAUREEN;JOHNSTON ROBERT;DAVIS NANCY;SWANSTROM RONALD
分类号 A61K39/00;A61K39/21;C07K14/16;C07K14/18;C12N7/02;(IPC1-7):A61K48/00;A61K39/12;C07H21/04;A01N63/00;C07K1/00;C07K14/00;C07K17/00 主分类号 A61K39/00
代理机构 代理人
主权项
地址